Style | Citing Format |
---|---|
MLA | Samavarchitehrani A, et al.. "Exploring the Tyg Index and the Homeostasis Model Assessment of Insulin Resistance As Insulin Resistance Markers: Implications for Fibromyalgia Management and Understanding—A Narrative Review." Diagnostics, vol. 15, no. 4, 2025, pp. -. |
APA | Samavarchitehrani A, Mercantepe F, Behnoush AH, Klisic A (2025). Exploring the Tyg Index and the Homeostasis Model Assessment of Insulin Resistance As Insulin Resistance Markers: Implications for Fibromyalgia Management and Understanding—A Narrative Review. Diagnostics, 15(4), -. |
Chicago | Samavarchitehrani A, Mercantepe F, Behnoush AH, Klisic A. "Exploring the Tyg Index and the Homeostasis Model Assessment of Insulin Resistance As Insulin Resistance Markers: Implications for Fibromyalgia Management and Understanding—A Narrative Review." Diagnostics 15, no. 4 (2025): -. |
Harvard | Samavarchitehrani A et al. (2025) 'Exploring the Tyg Index and the Homeostasis Model Assessment of Insulin Resistance As Insulin Resistance Markers: Implications for Fibromyalgia Management and Understanding—A Narrative Review', Diagnostics, 15(4), pp. -. |
Vancouver | Samavarchitehrani A, Mercantepe F, Behnoush AH, Klisic A. Exploring the Tyg Index and the Homeostasis Model Assessment of Insulin Resistance As Insulin Resistance Markers: Implications for Fibromyalgia Management and Understanding—A Narrative Review. Diagnostics. 2025;15(4):-. |
BibTex | @article{ author = {Samavarchitehrani A and Mercantepe F and Behnoush AH and Klisic A}, title = {Exploring the Tyg Index and the Homeostasis Model Assessment of Insulin Resistance As Insulin Resistance Markers: Implications for Fibromyalgia Management and Understanding—A Narrative Review}, journal = {Diagnostics}, volume = {15}, number = {4}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Samavarchitehrani A AU - Mercantepe F AU - Behnoush AH AU - Klisic A TI - Exploring the Tyg Index and the Homeostasis Model Assessment of Insulin Resistance As Insulin Resistance Markers: Implications for Fibromyalgia Management and Understanding—A Narrative Review JO - Diagnostics VL - 15 IS - 4 SP - EP - PY - 2025 ER - |